Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice

<p>Abstract</p> <p>Background</p> <p>Economic implications of chemotherapy-induced febrile neutropenia (FN) in European and Australian clinical practice are largely unknown.</p> <p>Methods</p> <p>Data were obtained from a European (97%) and Australian (3%) observational study of patients with non-Ho...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Weycker Derek, Danel Aurelie, Marciniak Anne, Bendall Kate, Lipsitz Michael, Pettengell Ruth
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2012-08-01
Edice:	BMC Cancer
Témata:	Febrile neutropenia Costs and cost analysis Non-Hodgkin’s lymphoma
On-line přístup:	http://www.biomedcentral.com/1471-2407/12/362
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!